• Hana Pharm corrected its Pyeongtaek factory investment end date to Dec. 28, 2026, from Oct. 18, 2026.
• The revised date reflects expected completion of investment payments rather than the originally scheduled factory completion.
• The investment totals 56.76 billion won, equivalent to 18.36% of equity, to expand production capacity and strengthen export competitiveness.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hana Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016800681), on October 16, 2026, and is solely responsible for the information contained therein.